Thomas is an experienced supply chain consulting leader with more than 25 years of experience helping companies design, optimize, and transform complex supply chains, with a strong focus on the pharmaceutical sector.
Prior to joining AIM, Thomas held leadership roles at CAMELOT, McKinsey & Company, and Accenture. His work has focused on supply chain strategy and transformation, digital innovation, operating model design, planning excellence, supply chain resilience, and sustainable value chain development.
Thomas is passionate about helping organizations turn their supply chains into a value engine for the business, combining strategic perspective with practical, end-to-end transformation experience.
At AIM, Thomas focuses on expanding the firm’s end-to-end supply chain capabilities, supporting clients with supply chain diagnostics and strategy, end-to-end planning optimization, supply reliability, and working capital optimization, among others. He holds a master’s degree in business management from Otto-Friedrich-Universität Bamberg.
Marleen has over 20 years of supply chain experience in the biopharma industry, managing both regional and global supply and demand processes for biologics, cell therapies and vaccines. Prior to joining AIM, she spent over five years in supply chain leadership roles at Kite Pharma, a Gilead company, supporting the startup, growth and commercialization of innovative cell therapies. Before Kite, she spent nearly 10 years in supply chain leadership roles at Janssen, where her responsibilities included designing and implementing the supply chain processes and teams for pandemic supply chains and US CAR-T therapies. Earlier in her career, she spent over 5 years at Centocor, building a strong foundation in biopharmaceutical supply chain operations.
Marleen holds a APICS certification and is a J&J certified black belt. She is experienced in process development and improvement, organizational design, and talent engagement and management. Marleen is a strong communicator, cross-functional collaborator, and enjoys getting the job done.
Jordy holds an M.Sc. in Finance from the University of Tilburg and has more than 10 years of experience in supply chain management and finance, primarily in the biopharmaceutical industry.
Jordy held multiple functional roles in Amgen’s regional supply chain for 8+ years, leading cross-functional global projects and optimizing value chains as a Supply Chain Manager.
He started in supply allocation management and spent 3 years in Ireland as demand and inventory manager, implementing and overseeing the launch of Amgen’s biosimilar.
Jordy is a practical, highly skilled, and collaborative professional. With a strong background in finance, he developed a passion for the biopharmaceutical industry and end-to-end supply chain management.
Renske is the Operations Manager at AIM. With a background in accounting, office management, and business operations, she brings a broad range of expertise to the organization. After spending 10 years as a bookkeeper at a mid-sized accountancy firm and later serving as Office Manager in the fashion industry, she joined AIM in 2018 to oversee the company’s financial administration. Since becoming full-time in 2021, her role has expanded to include Human Resources, office operations, and overall operational management. Today, Renske is responsible for ensuring that AIM’s finance, people, processes, and daily operations run efficiently, reflecting her versatility and cross-functional leadership within the company.
One of Renske’s passions is to create a flawless back-office environment for AIM.
Rolf is an experienced leader in supply chain and operations functions in the pharmaceutical and medical device industries, with many years working as a member of company senior management teams.
His specialties are purchasing, planning, (cold-chain) warehousing and distribution, supplier selection and contract management, management of outsourced operations, and management of assembly and packaging operations.
Rolf’s background includes leadership roles at Synthon (VP, Global Supply Chain), Quanta Dialysis Technologies (Chief of Operations), Biocartis (Director of Supply Chain and External Manufacturing), and MSD / Schering Plough / Akzo Nobel / Intervet (Director, Outbound Operations).
As a leader, Rolf is practical, eloquent, used to changing environments and result-oriented with a focus on the human factors involved. He is a highly effective team player and is excellent at maintaining open lines of communication.
Ronald has a BSc in commercial economics and a substantial background in the biopharma industry. He has held senior management positions in 4 globally operating companies of which two biopharmaceutical companies. He has experience in sales and marketing, change management, and continuous improvement.
However, his primary focus has been on supply chains. Over 22+ years, he has covered all of the typical functional areas within end-to-end life science supply chains. Ronald is a holistic thinker who understands what it takes to build supply chains, as well as improve them to exceed customers’ expectations.
“I love to work across cultures and in highly complex and cross-functional settings, letting the team-diversity do the magic while having a clearly defined and ambitious game-plan.”
Richard is an experienced executive in the life science and chemical industries. In 2009, he founded AIM. Prior to AIM, Richard served in leadership roles at Genzyme and Ashland (Hercules).
At Genzyme, Richard was Head of Customer Service for the EMEA region. While there, he transitioned from in-house warehousing to a European external third-party logistics provider (3PL). He also restructured the customer service organization, was involved in multiple product launches, and managed the supply chain.
Richard held multiple roles at Ashland, including Head of the EMEA Customer Care team. While there, he led various improvements, including re-engineering the customer service team, introducing the key performance indicator concept, and standardizing numerous work processes. The result was a double-digit improvement in the quality of customer service.
Also while at Ashland, Richard served as a Global Accounts Manager. He worked closely with accounts like Unilever, Procter & Gamble, GlaxoSmithKline, and AstraZeneca. He generated year over year double-digit business growth and was involved with multiple new product development projects and launches.
